Posts by lla@whitesharkmedia.com

As 2025 unfolds, businesses operating in FDA-regulated industries are facing a fresh wave of challenges due to new tariff increases. These changes bring added pressure to pharmaceutical and medical device manufacturers, with potential implications on cost, supply chain efficiency, and regulatory compliance. Companies must now align their FDA compliance efforts with customs and trade requirements…